WADHURST MEDICAL GROUP — All Prescriptions & Medications — Page 9
Practice Code: G81030 | WADHURST, TN5 6BJ
Showing results 401-450 of 600
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 29 | 207 | £467 | +20.0% ▲ | |
| Verapamil hydrochloride | 28 | 2,184 | £121 | -69.1% ▼ |
| Nicotine | 28 | 729 | £1.1K | -50.4% ▼ |
| Biphasic insulin aspart | 28 | 160 | £957 | -72.4% ▼ |
| Mercaptopurine | 28 | 1,513 | £649 | +80.8% ▲ |
| 28 | 900 | £1.2K | +71.5% ▲ | |
| Loprazolam mesilate | 27 | 385 | £302 | +104.0% ▲ |
| Pethidine hydrochloride | 27 | 370 | £189 | +209.4% ▲ |
| Insulin Lispro | 27 | 244 | £1.5K | -64.7% ▼ |
| Denosumab | 27 | 27 | £4.9K | -0.8% vs avg |
| Mycophenolate mofetil | 27 | 4,720 | £645 | -33.3% ▼ |
| Adapalene | 27 | 2,115 | £734 | +23.4% ▲ |
| 27 | 270 | £721 | +32.2% ▲ | |
| Colestyramine | 26 | 1,552 | £579 | -9.7% ▼ |
| Dexamfetamine sulfate | 26 | 1,960 | £1.5K | -27.7% ▼ |
| Powder thickener - gum based (0913161) | 26 | 8,175 | £476 | -65.4% ▼ |
| Febuxostat | 26 | 784 | £121 | -30.4% ▼ |
| Hepatitis A/hepatitis B | 26 | 26 | £760 | +53.7% ▲ |
| 26 | 365 | £1.3K | -6.5% ▼ | |
| Metoprolol tartrate | 25 | 1,148 | £812 | -50.7% ▼ |
| Losartan potassium with diuretic | 25 | 1,232 | £179 | -2.5% ▼ |
| Codeine phosphate | 25 | 5,000 | £162 | +74.2% ▲ |
| Benzydamine hydrochloride | 25 | 5,370 | £107 | -67.7% ▼ |
| Azelaic acid | 25 | 780 | £154 | +4.6% ▲ |
| 25 | 1,893 | £3.2K | +18.1% ▲ | |
| 25 | 1,420 | £67 | -53.9% ▼ | |
| Colesevelam hydrochloride | 24 | 4,320 | £2.5K | -36.7% ▼ |
| Indacaterol/glycopyrronium | 24 | 1,050 | £1.1K | -46.8% ▼ |
| Testosterone undecanoate | 24 | 28 | £2.4K | -5.5% ▼ |
| Levonorgestrel | 24 | 25 | £2.1K | -36.4% ▼ |
| Powder extensively hydrolysed formula (0913101) | 24 | 99.6K | £3.0K | -66.7% ▼ |
| Tizanidine hydrochloride | 24 | 3,696 | £403 | -9.4% ▼ |
| Betamethasone esters | 24 | 1,270 | £146 | -60.2% ▼ |
| Terbinafine hydrochloride | 24 | 615 | £114 | -35.3% ▼ |
| 24 | 172 | £1.5K | +36.6% ▲ | |
| 24 | 242 | £188 | -36.2% ▼ | |
| 24 | 260 | £350 | +148.4% ▲ | |
| Budesonide | 23 | 2,267 | £1.8K | +46.8% ▲ |
| Clobazam | 23 | 4,092 | £1.7K | -65.1% ▼ |
| Erythromycin | 23 | 764 | £305 | -33.6% ▼ |
| Tacrolimus | 23 | 4,100 | £5.7K | -14.0% ▼ |
| Meloxicam | 23 | 1,110 | £30 | -65.2% ▼ |
| 23 | 540 | £109 | -31.1% ▼ | |
| 23 | 1,061 | £226 | -21.7% ▼ | |
| Dabigatran etexilate | 22 | 1,320 | £1.0K | -57.5% ▼ |
| Dipyridamole | 22 | 1,320 | £275 | -14.3% ▼ |
| Nefopam hydrochloride | 22 | 1,920 | £98 | -80.6% ▼ |
| Brivaracetam | 22 | 1,232 | £2.9K | -35.3% ▼ |
| Midazolam hydrochloride | 22 | 360 | £8.2K | +52.7% ▲ |
| Dutasteride | 22 | 840 | £74 | -57.2% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.